Since then, intensive studies have confirmed that cGAS–STING plays a significant role not only in pathogenic microbial infection but also in a variety of DNA‐triggered inflammation‐related diseases such as cancer, autoimmune diseases, neurological and visceral inflammation, which makes cGAS–STING signaling pathway a potentially effective therapeutic target for inflammatory diseases.6, 7, 8. This evidence concerns the gene STING1 and autoimmune disease.